MSACL 2024Monterey, CA : March 17-22 |
|
MSACL 2024
14th Annual Conference & Exhibits
Monterey, CA
March 17 - 22, 2024
|
|
|

In support of improving patient care, this activity has been planned and implemented by University of Nebraska Medical Center and Mass Spectrometry & Advances in the Clinical Lab (MSACL). University of Nebraska Medical Center
is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing
education for the healthcare team.
The University of Nebraska Medical Center designates this live activity for a maximum of 33.45 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
You will receive a link with instructions to claim your CME credits upon completion of the conference feedback questionnaire.
IMPORTANT : You will have only 20 days to claim your credits. There is zero flexibility on this.
More info on CME Accreditation at MSACL here.
MSACL's mission is to support the community in overcoming the challenges of implementing high value tests in the clinical lab.
MSACL is focused on providing a forum of interaction for participants in all stages of the development, advancement and use of analytical tools, including data analytics, in the clinic to improve patient care. Although the group primarily focuses on mass spectrometry, presentations and discussion on other platforms are welcome.
The Monterey Conference Center (MCC) is flanked by two hotels, the Marriott, and the Portola. Each has meeting space and their own restaurant. Local sourcing is a priority. Portola also has a brewpub (Peter B’s).
We will be using the Monterey Conference Center’s Serra Ballroom as the MSACL Exhibit Hall (19,150 square feet). There will be space for at ~34 booths interspersed with up to 172 posters.
We had 530 attendees for MSACL 2023. We are expecting about 580-650 for MSACL 2024.